How I Manage Patients with Frequent PVCs

Stanford Medicine

R. John

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

The Texas Heart Institute

M. Razavi

Postural Tachycardia Syndrome: Pathophysiology and Impact of Tragus …

Virtual EP Connect

V. Reddy, F. Marchlinski, T. Glotzer, B. Olshansky, S. Po, S. Stavrakis

Top 5 Arrhythmias You Need to Know

Joel Gorfinkel

Treatment of HF Beyond CRT: How Effective Are Cardiac Contractility …

Houston Methodist DeBakey Heart and Vascular Center

P. Schurmann

Antiarrhythmic Drugs for AF in the Outpatient Setting

Mayo Clinic Proceedings

C. Desimone

Atrial Fibrillation: Past, Present and Future

Houston Methodist DeBakey Heart and Vascular Center

P. Ellinor

Atrial Fibrillation - Current Guidelines and Future Directions

Jefferson Health

R. Borge

Hybrid AFib Ablation: Persistent AFib Management in the Current Era

Nitesh Sood

Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation - i…

Cedars Sinai

J. Mandrola

Management of Ventricular Tachycardia

Scripps Health

D. Gibson

AF Ablation as First-Line Therapy: Benefit vs Risk

Virtual EP Connect

V. Reddy, F. Marchlinski, J. Andrade, H. Calkins, V. Fuster, S. Dukkipati

AHA 2022: Risk Stratification and Treatment of Ventricular Arrhythmi…

AHA 2022 Conference Coverage

E. Kaufman

PVCs and Their Significance

Michigan Medicine

F. Bogun

ACC 2023: Is Rhythm Control Ever Good Enough?

ACC 2023 Conference Coverage

B. Olshansky

AHA 2022: Updates in Atrial Fibrillation Ablation and Management

AHA 2022 Conference Coverage

R. Cappato

COVID-19 Cardiac Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

B. Bozkurt

Frontiers and Advances in Arrhythmia Management

University of Colorado Department of Medicine

W. Tzou

Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation

Cedars Sinai

M. Kittleson

2021 Approach to Rhythm Management and Heart Failure: from Afib to VT

Cleveland Clinic Heart, Vascular and Thoracic Institute

M. Bhargava